 |
|
Potential pathway for drug intervention
March 16, 2009LA JOLLA, CA-A newly identified molecular pathway that directs stem cells to produce glial cells yields insights into the neurobiology of Down's syndrome and a number of central nervous system disorders characterized by too many glial cells, according to a recent study by researchers at the Salk Institute for Biological Studies.
Their findings, to be published in the March 13 online edition of Cell Death and Differentiation, indicate that synaptojanin-1, a central component of the pathway, is essential to production of glia, brain cells that act as neurons' personal assistants. Down's syndrome, spinal cord injury, Alzheimer's disease, and stroke all are linked by an overproduction of glia. Understanding this molecular pathway may also have implications for the onset of glioblastoma, the most common and malignant type of brain tumor.
With the relevance of glia to human central nervous system function and pathology already widely accepted, Salk professor David Schubert, who heads the Cellular Neurobiology Laboratory, observes: "The discovery of this molecular signaling pathway promises to completely change the way we think about central nervous system maladies, allowing the development of drugs that inhibit glial proliferation and improve the prognosis of patients with a host of devastating conditions."
Down's syndrome is the most frequent cause of mental retardation, with an incidence of 1 of every 800 births. Cognitive deficits, as well as changes in the basic composition of the brain, are observed soon after birth, reflecting problems in brain development. Although it is known that Down's syndrome is caused by an extra copy of chromosome 21, the exact genetic details largely remain a mystery.
Among the established anomalies found in the brains of Down's syndrome patients are a greater than normal number of glial cells and perhaps fewer nerve cells. The reason for these characteristics has been unclear, however. Using a new mass spectrometry technique and stem cells that can be made to produce either neurons or glia, a team of Salk researchers led by first author Federico Herrera, Ph.D., a senior scientist in the Cellular Neurobiology Laboratory, identified a molecular signaling pathway that is required for the production of glial cells.
He and his colleagues then sought to determine whether the pathway was more active in Down's syndrome patients and a mouse model of the condition. What they found was that the level of a protein called synaptojanin-1, which is encoded in chromosome 21, is much higher in both and is strongly correlated with a greater number of glial cells.
"Given the required balance between the numbers of neurons and glia in a normal brain, an excess of glia may contribute to the cognitive deficits that characterize Down's syndrome," says Herrera. The team also found that Synaptojanin-1 was not required for the production of neurons, and they identified the particular part of the Synaptojanin-1 molecule that was responsible for generating glia. "This is a critical first step to identifying drugs that specifically block the excess proliferation of glial cells associated with Down's syndrome and perhaps promote the production of more neurons," Herrera adds.
Furthermore, the medical implications of this discovery extend beyond Down's syndrome. According to Schubert, a surplus of glial cells is detrimental to the regeneration of nerves following spinal injury. "It is thought that the aberrant accumulation of glial cells around the site of spinal injury, the so-called glial scar, actively inhibits nerve regeneration," he says.
Increased production of glial cells is frequently seen in other conditions as well, including stroke and neurodegenerative disorders such as Alzheimer's disease, and may contribute to the brain damage associated with them. Interestingly, a large proportion of Down's syndrome patients develop Alzheimer's disease at a young age, and Herrera believes that a higher proportion of glial cells could be a contributing factor.
Abnormal production of glia is also implicated in glioblastoma, the most common and malignant of brain tumors, which is thought to be caused by the inappropriate generation of glia from brain stem cells. While normal glia only proliferate when the brain suffers some kind of injury, the defective glia found in glioblastomas proliferate spontaneously. "In this case, our findings could be used to transform tumor cells into normal glia," says Herrera.
Salk Institute
Down's syndrome is the most frequent cause of mental retardation, with an incidence of 1 of every 800 births. Cognitive deficits, as well as changes in the basic composition of the brain, are observed soon after birth, reflecting problems in brain development. Although it is known that Down's syndrome is caused by an extra copy of chromosome 21, the exact genetic details largely remain a mystery.
Among the established anomalies found in the brains of Down's syndrome patients are a greater than normal number of glial cells and perhaps fewer nerve cells. The reason for these characteristics has been unclear, however. Using a new mass spectrometry technique and stem cells that can be made to produce either neurons or glia, a team of Salk researchers led by first author Federico Herrera, Ph.D., a senior scientist in the Cellular Neurobiology Laboratory, identified a molecular signaling pathway that is required for the production of glial cells.
He and his colleagues then sought to determine whether the pathway was more active in Down's syndrome patients and a mouse model of the condition. What they found was that the level of a protein called synaptojanin-1, which is encoded in chromosome 21, is much higher in both and is strongly correlated with a greater number of glial cells.
"Given the required balance between the numbers of neurons and glia in a normal brain, an excess of glia may contribute to the cognitive deficits that characterize Down's syndrome," says Herrera. The team also found that Synaptojanin-1 was not required for the production of neurons, and they identified the particular part of the Synaptojanin-1 molecule that was responsible for generating glia. "This is a critical first step to identifying drugs that specifically block the excess proliferation of glial cells associated with Down's syndrome and perhaps promote the production of more neurons," Herrera adds.
Furthermore, the medical implications of this discovery extend beyond Down's syndrome. According to Schubert, a surplus of glial cells is detrimental to the regeneration of nerves following spinal injury. "It is thought that the aberrant accumulation of glial cells around the site of spinal injury, the so-called glial scar, actively inhibits nerve regeneration," he says.
Increased production of glial cells is frequently seen in other conditions as well, including stroke and neurodegenerative disorders such as Alzheimer's disease, and may contribute to the brain damage associated with them. Interestingly, a large proportion of Down's syndrome patients develop Alzheimer's disease at a young age, and Herrera believes that a higher proportion of glial cells could be a contributing factor.
Abnormal production of glia is also implicated in glioblastoma, the most common and malignant of brain tumors, which is thought to be caused by the inappropriate generation of glia from brain stem cells. While normal glia only proliferate when the brain suffers some kind of injury, the defective glia found in glioblastomas proliferate spontaneously. "In this case, our findings could be used to transform tumor cells into normal glia," says Herrera.
Salk Institute
Glial Cells Current Events and Glial Cells News RSSRethinking Alzheimer's disease and its treatment targets
The standard explanation for what causes Alzheimer's is known as the amyloid hypothesis, which posits that the disease results from of an accumulation of the peptide amyloid beta, the toxic protein fragments that deposit in the brain and become the sticky plaques that have defined Alzheimer's for more than 100 years.
Are the monoamines involved in shaping conduct disorders?
Antisocial and aggressive behaviours represent a widespread and expensive social problem. Recent research has convincingly shown that there is a strong interaction between genetic inheritance and environment for development of personality and behaviour.
NIH researchers identify key factor that stimulates brain cancer cells to spread
Researchers funded by the National Institutes of Health have found that the activity of a protein in brain cells helps stimulate the spread of an aggressive brain cancer called glioblastoma multiforme (GBM).
St. Jude scientists discover a new mechanism controlling neuronal migration
The molecular machinery that helps brain cells migrate to their correct place in the developing brain has been identified by scientists at St. Jude Children's Research Hospital.
CU-Boulder study shows brain's immune system may cause chronic seizures
Chronic seizures caused by traumatic head injuries may result from chemicals released by the brain's immune system attempting to repair the injured site.
Popular Alzheimer's theory may be false trail
The idea that anti-inflammatory drugs might protect people struggling with dementia from Alzheimer's disease has received a blow with the online release of a study of human brain tissue in Acta Neuropathologica.
Cell's split personality is a major discovery into neurological diseases
Researchers at the Université de Montreal (UdeM) and the Montreal Neurological Institute (MNI), McGill University have discovered that cells which normally support nerve cell (neuron) survival also play an active and major role in the death of neurons in the eye.
Inexpensive drug appears to relieve fibromyalgia pain in Stanford pilot study
For Tara Campbell, the onset of her fibromyalgia began slowly with repeated sore throats, fevers and fatigue. By the time she was diagnosed, a year later, she had become so debilitated by flulike symptoms and exhaustion that she often couldn't get off the couch all day.
Experts examine causes, treatment and prevention of glaucoma
Although scientists know progressive degeneration of retinal ganglion cells and their axons is the primary cause of glaucoma, researchers have yet to identify a way to stop or prevent the degeneration.
RSRT Advisor Makes Significant Discovery with Potential for Novel Therapeutic Approaches
A paper published online today in Nature Neuroscience reveals the presence of methyl CpG binding protein 2 (MeCP2) in glia. MeCP2 is a protein associated with a variety of neurological disorders, including Rett Syndrome, the most physically disabling of the autism spectrum disorders.
More Glial Cells Current Events and Glial Cells News Articles
 |
Glial Cell Function, Volume 132 (Progress in Brain Research) by B. Castellano López (Editor), M. Nieto-Sampedro (Editor) Although knowledge of the development and differentiation of glial cells has significantly increased in recent years, there are still many questions unanswered. The first section of the book is devoted to this very active topic and includes contributions on Schwann cells, oligodendrocytes, astroglia and microglia. The second section of the book covers cellular interactions, the role they play on myelination and remyelination, how these interactions take place and the molecules involved.
The topic of how glial cells react to... |
 |
The Root of Thought: Unlocking Glia- the Brain Cell That Will Help Us Sharpen Our Wits, Heal Injury, and Treat Brain Disease by Andrew Koob (Author) Discover the Other 90% of Your Brain *Learn about brain science breakthroughs that might hold the key to intelligence, creativity, and imagination.*Discover amazing cells that keep your brain growing, adapting, and healing.*Preview possible breakthroughs for brain cancer, brain trauma, Alzheimer's, Parkinson's, and even schizophrenia. If you know anything about brains, you've heard of neurons. Those are the cells that have long been seen as central to virtually everything your brain thinks, feels, and does. But neurons represent only 10% of your brain cells. What does the other 90% do? Until recently, scientists didn't have a clue. Now, they're discovering the real function of those long-neglected glial cells--and the story is nothing short of amazing. In The Root of Thought, brain... |
 |
Glial Cells: Their Role in Behaviour by Peter R. Laming (Editor), Eva Syková (Editor), Andreas Reichenbach (Editor), Glenn I. Hatton (Editor), Herbert Bauer (Editor) In mammals the glial (or glue) cells contribute some fifty percent of the volume of the brain. In contrast to the traditional view that they have a purely physically supportive role, research in the past three decades has shown that glia interact morphologically, biochemically, and physiologically with neurons during changes in behavior. The evidence suggests that glia may modulate neuronal activity and thereby influence behavior. This is the first book that describes and discusses these neuronal-glial interactions in relation to behavior. A distinguished set of authors addresses these interactions from a number of viewpoints. |
|
GLIAL CELL DEVELOPMENT (Molecular and Cellular Neurobiology Series) by Kristjan R. Jessen (Editor), William D. Richardson (Editor) Glial cell function and development has become a major focus of research in the neurosciences. Distinct glial progenitors have been identified, key glial genes have been cloned, and the growth factor regulation of glial survival, proliferation, and function are being unraveled. As a result, it will soon be possible to understand at the molecular level some vital functions, such as myelination and regulation of axon growth and repair. In this book, leading researchers review the current state of knowledge of all classes of glia and describe how this knowledge is being applied to the treatment of human disease. It is a valuable reference book for all researchers in developmental biology and neuroscience. | |
|
Science Magazine 21 May 1993: (Book Issue)a Glial Cell Line by American Association for the Advancement of Science (Author) | |
![Glial cells for information routing? [An article from: Cognitive Systems Research]](http://ecx.images-amazon.com/images/I/41FWP1RKRDL._SL160_.jpg) |
Glial cells for information routing? [An article from: Cognitive Systems Research] by C. Moller (Author), J. Lucke (Author), J. Zhu (Author), P.M. Faustmann (Author), von d (Author) This digital document is a journal article from Cognitive Systems Research, published by Elsevier in 2007. The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser. Description: We investigate a possible functional role of glial cells as information routing devices of the cerebral cortex. On the one hand, functionally motivated models of neural information processing were lately suggested which rely on short-term changes of connections between neural modules to dynamically route neural activity. Although successful in practice, the routing mechanisms of these models require synaptic efficacy control of large sets of synapses that is difficult to implement neurally. On the other... |
|
Neuronal-Glial Cell Interrelationships (Dahlem Workshop Reports) by Theresa Ann Sears (Author) | |
|
Glial Cell Receptors by Harold K. Kimelberg (Editor) | |
 |
Influence of Glial Cells on Postnatal Differentiation of Neurons by Christian Göritz (Author) |
 |
Molecular Signaling and Regulation in Glial Cells: A Key to Remyelination and Functional Repair by Jeserich (Editor), Hans H. Althaus (Editor), C. Richter-Landsberg (Editor), R. Heumann (Editor) An excellent survey of the most recent advances in the area of cellular and molecular biology of glial cells and their involvement in remyelination and functional repair in the CNS. A major part of this book deals with signaling paths within and among neural cells. Glial cells (astrocytes, oligodentrocytes, microglial cells) themselves release substantial amounts of cytokines, growth factors and other signaling molecules, which play an important role during injury and regeneration. Another signaling route between neurons and glial cells follows ion channels and neurotransmitter receptors. In addition to animal models, human oligodentrocytes in cell culture and in the human MS brain are characterized with respect to their immunocytochemistry and function. |
| © 2009 BrightSurf.com |